Mirae Asset Global Investments »

Tourmaline Bio shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $18k 854 20.68
2024-09-30 $23k 927 25.00
2024-06-30 $10k 766 13.23

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Eli Lilly & Co. (LLY)

View all positions for Mirae Asset Global Investments

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Vanguard Group
Jennison Associates
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Millennium Management
Geode Capital Management
Citadel Advisors

View all funds holding Tourmaline Bio